aTyr Pharma | LIFE - Current Liabilities


aTyr Pharma reported $113.19M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Ardelyx USD 88.6M 5.22M Dec/2025
aTyr Pharma USD 113.19M 97.51M Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Galapagos EUR 152.86M 213.7M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Roche Holding CHF 28B 421M Dec/2025
United Therapeutics USD 560.6M 14.3M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025